Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns

Zhao, Ya'ning; Bai, Jun; Wang, Xi; Zhang, Yaoren; Yan, Xiaohong; Qi, Jun'an; Xia, Xueyan; Feng, Yuansong; Duan, Baojun

doi:10.7150/jca.93885



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2024; 15(8):2193-2205. doi:10.7150/jca.93885 This issue Cite

Review

Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns

Ya'ning Zhao¹, Jun Bai², Xi Wang², Yaoren Zhang³, Xiaohong Yan¹, Jun'an Qi⁴, Xueyan Xia², Yuansong Feng², Baojun Duan^1,2✉

1. Department of Medical Oncology of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
2. Department of Medical Oncology of Shaanxi Provincial People's Hospital, Xi'an 710068, Shaanxi Province, China.
3. Department of Ultrasonography of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.
4. Department of Hepatobiliary Surgery of Baoji Central Hospital, Baoji 721008, Shaanxi Province, China.

Citation:

Zhao Y, Bai J, Wang X, Zhang Y, Yan X, Qi J, Xia X, Feng Y, Duan B. Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns. J Cancer 2024; 15(8):2193-2205. doi:10.7150/jca.93885. https://www.jcancer.org/v15p2193.htm

Other styles

Abstract

With the development of guidance technology and ablation equipment, ablative procedures have emerged as important loco-regional alternatives to surgical resection for recurrent hepatocellular carcinoma (rHCC) patients. Currently, ablation modalities used in clinical practice mainly include radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), cryoablation (CRA), high-intensity focused ultrasound (HIFU), and irreversible electroporation (IRE). Accumulated comparative data of ablation versus surgical resection reveal noninferior responses and outcomes but superior adverse effects. Moreover, studies demonstrate that ablation may serve as an excellent procedure for rHCC given its exact minimal invasiveness and immune modulation. We focus on the current status of ablation in clinical practice for rHCC and discuss new research in the field, including ablation combined with these other modalities, such as targeted therapy and immunotherapy.

Keywords: Ablation, HCC, RFA, MWA

Citation styles

APA

Zhao, Y., Bai, J., Wang, X., Zhang, Y., Yan, X., Qi, J., Xia, X., Feng, Y., Duan, B. (2024). Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns. Journal of Cancer, 15(8), 2193-2205. https://doi.org/10.7150/jca.93885.

ACS

Zhao, Y.; Bai, J.; Wang, X.; Zhang, Y.; Yan, X.; Qi, J.; Xia, X.; Feng, Y.; Duan, B. Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns. J. Cancer 2024, 15 (8), 2193-2205. DOI: 10.7150/jca.93885.

NLM

CSE

Zhao Y, Bai J, Wang X, Zhang Y, Yan X, Qi J, Xia X, Feng Y, Duan B. 2024. Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns. J Cancer. 15(8):2193-2205.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.